Home
About
Company Profile
History
Corporate Philosophy
Honors
Holding company
Social Responsibility
Factory Tour
Management Team
Investor Relations
Innovative R&D
R&D Team
R&D Conditions
Technology Platform
Research Collaboration
Research paper
R&D platform
Products under development
Sales & Marketing
Listed Products
Vaccination Site Notice
Batch Release Status
Pharmaceutical Representative Filing Information
Delivery Provider Disclosure
Mandatory Vaccine Insurance
Blog
Hundred Grams News
Employee Activities
Industry Information
Visualized Periodic Reports
Supervisory Management
GMP Implementation Status
Quality Management
Recall Status
Undergo inspection
Penalty Details
邮箱:bcht@bchtpharm.com
电话:400-8845-777
BLOG
15
2026/05
Resist the lure of illegal stock recommendations and fortify the defense of rational investing—2026 National Campaign for Raising Awareness on Preventing Illegal Securities, Futures, and Fund Activities
Putting Investors First, Acting Together—2026 “May 15 National Investor Protection Public Awareness Day” Event
22
2026/04
Baike Bio’s 2025 Annual Report and First Quarter 2026 Report
11
2026/03
“A Clean and Transparent Financial Internet, Safeguarding Peace of Mind in Investment” —— 2026 “3·15” Investor Protection Education and Public Awareness Campaign
19
2025/11
Innovation Leads the Future: The 2025 China Vaccine Academic Conference Concludes Successfully, with Bio-Thera Solutions Showcasing Several Flagship Products
07
Baike Bio’s Third Quarter Report for 2025